Solventum Corporation (SOLV)

Market Cap	14.79B
Revenue (ttm)	8.40B
Net Income (ttm)	1.52B
Shares Out	173.45M
EPS (ttm)	8.72
PE Ratio	9.78
Forward PE	13.66
Dividend	n/a
Ex-Dividend Date	n/a

Volume	988,051
Open	85.77
Previous Close	85.77
Day's Range	85.25 - 86.81
52-Week Range	60.70 - 86.81
Beta	n/a
Analysts	Hold
Price Target	85.00 (-0.32%)
Earnings Date	Nov 6, 2025

About SOLV

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates in three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions for negative pressure wound therapy, advanced wound dressings, advanced skin care, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical e...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2023
• Employees: 22,000
• Stock Exchange: NYSE
• Ticker Symbol: SOLV
• Website: https://www.solventum.com

Financial Performance

In 2024, Solventum's revenue was $8.25 billion, an increase of 0.70% compared to the previous year's $8.20 billion. Earnings were $479.00 million, a decrease of -64.41%.

Analyst Summary

According to 10 analysts, the average rating for SOLV stock is "Hold." The 12-month stock price target is $85.0, which is a decrease of -0.32% from the latest price.

Price Target

$85.0

(-0.32% downside)

Analyst Consensus: Hold